Degenerative Disease of Nervous System, Unspecified clinical trials
15 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Home Exercise for Individuals with Neurodegenerative Disease
- Mindfulness Walking Intervention to Enhance Resilience (iWalk)
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Multidimensional Sleep Health Intervention for Couples
- Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders
- Human Observatory Study
- Observational Pharmaco-Epidemiology Research & Analysis
- Retinal Imaging in Neurodegenerative Disease
- The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
- Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Optimization of Adaptive Rowing Seating
- Fareon Open Label Device Clinical Trial
- Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
- Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research
- DaTSCAN Imaging in Aging and Neurodegenerative Disease
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Degenerative Disease of Nervous System, Unspecified” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.